Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed?

Jason J. Luke; Nageatte Ibrahim; Alexander MM Eggermont

doi:10.1016/S0140-6736(22)01350-2

Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed?

Jason J. Luke, Nageatte Ibrahim, Alexander MM Eggermont

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Originele taal-2	Engels
Pagina's (van-tot)	559-560
Aantal pagina's	2
Tijdschrift	Lancet
Volume	400
Nummer van het tijdschrift	10352
DOI's	https://doi.org/10.1016/S0140-6736(22)01350-2
Status	Gepubliceerd - 20 aug. 2022
Extern gepubliceerd	Ja

Toegang tot document

10.1016/S0140-6736(22)01350-2

Citeer dit

@article{62d8d298689f4fd3a62390a37928618a,

title = "Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed?",

keywords = "Biopsy, Humans, Melanoma/pathology, Neoplasm Staging, Retrospective Studies, Sentinel Lymph Node Biopsy, Skin Neoplasms/pathology",

author = "Luke, {Jason J.} and Nageatte Ibrahim and Eggermont, {Alexander MM}",

year = "2022",

month = aug,

day = "20",

doi = "10.1016/S0140-6736(22)01350-2",

language = "English",

volume = "400",

pages = "559--560",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10352",

}

TY - JOUR

T1 - Adjuvant therapy in stage IIB and IIC melanoma

T2 - is sentinel biopsy needed?

AU - Luke, Jason J.

AU - Ibrahim, Nageatte

AU - Eggermont, Alexander MM

PY - 2022/8/20

Y1 - 2022/8/20

KW - Biopsy

KW - Humans

KW - Melanoma/pathology

KW - Neoplasm Staging

KW - Retrospective Studies

KW - Sentinel Lymph Node Biopsy

KW - Skin Neoplasms/pathology

UR - http://www.scopus.com/inward/record.url?scp=85136214395&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(22)01350-2

DO - 10.1016/S0140-6736(22)01350-2

M3 - Article

C2 - 35988562

AN - SCOPUS:85136214395

SN - 0140-6736

VL - 400

SP - 559

EP - 560

JO - Lancet

JF - Lancet

IS - 10352

ER -